<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-10T20:22:47+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>肝细胞癌术后辅助治疗！恒瑞PD-1+阿帕替尼联合疗法启动 III 期临床</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/vs4bcjXYG4aa_3Z0e_yzag</id>
    <link href="https://mp.weixin.qq.com/s/vs4bcjXYG4aa_3Z0e_yzag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再鼎 Repotrectinib 启动临床，ALK/ROS1/NTRK 重排晚期实体瘤</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/RAwjTqcABbqIenfCuvI1qQ</id>
    <link href="https://mp.weixin.qq.com/s/RAwjTqcABbqIenfCuvI1qQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「奥贝胆酸片」报上市，国内尚无企业获批</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/d0u1Rc9Ot0OFHtGnKTVvWw</id>
    <link href="https://mp.weixin.qq.com/s/d0u1Rc9Ot0OFHtGnKTVvWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>齐鲁制药「地夸磷索钠滴眼液」第 2 家报上市</title>
    <updated>2020-12-10T18:28:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/NuRyptj9hjlF_Yk-oDXdzQ</id>
    <link href="https://mp.weixin.qq.com/s/NuRyptj9hjlF_Yk-oDXdzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！第 4 批国采开始报量，涉及 90 个品规（附品种+企业详情）</title>
    <updated>2020-12-09T13:38:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/50ry7UmsC9hz6lDl0m8BLg</id>
    <link href="https://mp.weixin.qq.com/s/50ry7UmsC9hz6lDl0m8BLg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首家！恒瑞继续发力眼科领域，「去氧肾上腺素酮咯酸溶液」报上市</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/DFiL15OFgsCxFC6BWTotGA</id>
    <link href="https://mp.weixin.qq.com/s/DFiL15OFgsCxFC6BWTotGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物药峰会！汇聚上海CPhI，5位行业大咖论道生物药研发新趋势！</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/WVPSuKUTiBbFobMLPeR3Sg</id>
    <link href="https://mp.weixin.qq.com/s/WVPSuKUTiBbFobMLPeR3Sg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>强生 Amivantamab 双抗国内启动 III 期临床，已向 FDA 递交 BLA</title>
    <updated>2020-12-08T18:31:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/tChk_Il871rULf386rxMlw</id>
    <link href="https://mp.weixin.qq.com/s/tChk_Il871rULf386rxMlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚！15 个仿制药获批，10 个仿制药通过一致性评价</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/HCYCGxsrSSq_qSmNozetOA</id>
    <link href="https://mp.weixin.qq.com/s/HCYCGxsrSSq_qSmNozetOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复宏汉霖「阿达木单抗」获批上市</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/5oynlcGKYM7WyrYc60jOmg</id>
    <link href="https://mp.weixin.qq.com/s/5oynlcGKYM7WyrYc60jOmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州/安进合作的「注射用倍林妥莫双抗」获批上市</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ym9FRGLHFolt1TywBUJriw</id>
    <link href="https://mp.weixin.qq.com/s/ym9FRGLHFolt1TywBUJriw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个 Bcl-2 抑制剂，艾伯维「维奈克拉片」获批上市</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/NLFNhVKbe9z50-wlnpw9WA</id>
    <link href="https://mp.weixin.qq.com/s/NLFNhVKbe9z50-wlnpw9WA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【不容错过】2020药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-07T18:25:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/t1IzbikxcJvkt_jwuIof3Q</id>
    <link href="https://mp.weixin.qq.com/s/t1IzbikxcJvkt_jwuIof3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年 11 月 CDE 药品审评报告</title>
    <updated>2020-12-04T19:07:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/fkx97jwmEIp0DFY5VadUGQ</id>
    <link href="https://mp.weixin.qq.com/s/fkx97jwmEIp0DFY5VadUGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>73 个品种符合第四批集采！涉及 128 家企业</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/Le_zaD34LZOACdrwxRwzSA</id>
    <link href="https://mp.weixin.qq.com/s/Le_zaD34LZOACdrwxRwzSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 4 款注射剂通过一致性评价，3 个为首家</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/QobbyGiXObCmGaw-doIKCg</id>
    <link href="https://mp.weixin.qq.com/s/QobbyGiXObCmGaw-doIKCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遗传性血管性水肿新药来了！「拉那芦人单抗」在国内获批</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/hkPTkwQj6hjDeB2SS7cXJA</id>
    <link href="https://mp.weixin.qq.com/s/hkPTkwQj6hjDeB2SS7cXJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴乙肝 1 类新药启动临床</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BLK-Y7NhtuK-cW4T1HErBQ</id>
    <link href="https://mp.weixin.qq.com/s/BLK-Y7NhtuK-cW4T1HErBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>参会须知 | ICDC2020-第三届肿瘤免疫及伴随诊断合作峰会</title>
    <updated>2020-12-04T18:43:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/BFNraIr5PvcB6jjvc50hmg</id>
    <link href="https://mp.weixin.qq.com/s/BFNraIr5PvcB6jjvc50hmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产 PARP 抑制剂！恒瑞 1 类新药「氟唑帕利胶囊」即将获批</title>
    <updated>2020-12-03T18:03:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/MwU0ApY37aXo79YnkZMRCA</id>
    <link href="https://mp.weixin.qq.com/s/MwU0ApY37aXo79YnkZMRCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>